DK0807178T3 - Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose - Google Patents

Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose

Info

Publication number
DK0807178T3
DK0807178T3 DK96902319T DK96902319T DK0807178T3 DK 0807178 T3 DK0807178 T3 DK 0807178T3 DK 96902319 T DK96902319 T DK 96902319T DK 96902319 T DK96902319 T DK 96902319T DK 0807178 T3 DK0807178 T3 DK 0807178T3
Authority
DK
Denmark
Prior art keywords
proteins
vaccines
detection
tuberculosis
same
Prior art date
Application number
DK96902319T
Other languages
English (en)
Inventor
Felix Romain
Anne Laqueyrerie
Gilles Marchal
Pascale Pescher
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0807178T3 publication Critical patent/DK0807178T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK96902319T 1995-02-01 1996-01-31 Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose DK0807178T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/382,184 US5714593A (en) 1995-02-01 1995-02-01 DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein

Publications (1)

Publication Number Publication Date
DK0807178T3 true DK0807178T3 (da) 2004-10-11

Family

ID=23507871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96902319T DK0807178T3 (da) 1995-02-01 1996-01-31 Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose

Country Status (12)

Country Link
US (7) US5714593A (da)
EP (1) EP0807178B1 (da)
JP (3) JPH10513349A (da)
AT (1) ATE268385T1 (da)
AU (1) AU700514B2 (da)
CA (1) CA2210928A1 (da)
DE (1) DE69632625T2 (da)
DK (1) DK0807178T3 (da)
ES (1) ES2217303T3 (da)
NZ (1) NZ301290A (da)
PT (1) PT807178E (da)
WO (1) WO1996023885A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714593A (en) 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) * 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1998016645A2 (en) * 1996-10-11 1998-04-23 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
FR2758144B1 (fr) * 1997-01-08 1999-04-02 Pasteur Institut Polynucleotide codant pour un polypeptide de 27 kd de mycobacteries appartenant au complexe de mycobacterium tuberculosis, application au diagnostic et a la prevention de la tuberculose
FR2766495B1 (fr) * 1997-07-22 2001-07-13 Pasteur Institut Souche de mycobacterium dont le gene erp est modifie et composition vaccinale la contenant
FR2767337B1 (fr) 1997-08-14 2002-07-05 Pasteur Institut Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
AU779978B2 (en) * 1999-10-07 2005-02-24 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US6316205B1 (en) * 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
AU2001241738A1 (en) * 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
DE60139963D1 (de) * 2000-06-20 2009-10-29 Corixa Corp Fusionsproteine aus mycobakterium tuberculosis
US7288261B2 (en) * 2000-07-10 2007-10-30 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
FR2818647B1 (fr) * 2000-12-21 2006-09-29 Pasteur Institut Glycopeptides immunogenes, criblage, preparation et applications
US20050267025A1 (en) * 2002-02-01 2005-12-01 Ho John L Compositions and methods for treatment of infectious and inflammatory diseases
AU2003210818A1 (en) * 2002-02-01 2003-09-02 Cornell Research Foundation, Inc. Compositions and methods for treatment of infectious and inflammatory diseases
US7026465B2 (en) * 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
ES2286212T3 (es) * 2002-02-25 2007-12-01 Pasteur Institut Secuencias suprimidas especificamente del genoma de mycobacterium tuberculosis, y su uso en el diagnostico y como vacunas.
CN100393876C (zh) * 2004-05-11 2008-06-11 中国人民解放军第三○九医院 用于结核病诊断的结核分枝杆菌蛋白
TWI285861B (en) * 2004-05-21 2007-08-21 Sanyo Electric Co Display device
US7820142B2 (en) 2004-09-30 2010-10-26 Institut Pasteur Immunogenic glycopeptides, screening, preparation and uses
US8475735B2 (en) * 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
US8303827B2 (en) * 2008-11-13 2012-11-06 Pixart Imaging Incorporation Method for making micro-electro-mechanical system device
EP2573107A1 (en) * 2011-09-21 2013-03-27 Norwegian Institute of Public Health A recombinant fusion protein
US10450349B2 (en) 2016-03-04 2019-10-22 Purdue Research Foundation Multivalent fibronectin-integrin binding compositions and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
FR2688785B1 (fr) * 1992-03-19 1995-07-07 Pasteur Institut Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.
US5714593A (en) 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein

Also Published As

Publication number Publication date
US6379902B1 (en) 2002-04-30
ATE268385T1 (de) 2004-06-15
US5866130A (en) 1999-02-02
US6221353B1 (en) 2001-04-24
AU700514B2 (en) 1999-01-07
US20030054008A1 (en) 2003-03-20
WO1996023885A1 (fr) 1996-08-08
AU4667596A (en) 1996-08-21
US7101555B2 (en) 2006-09-05
DE69632625D1 (de) 2004-07-08
PT807178E (pt) 2004-10-29
JP4283872B2 (ja) 2009-06-24
US5714593A (en) 1998-02-03
US6676945B2 (en) 2004-01-13
JPH10513349A (ja) 1998-12-22
EP0807178B1 (fr) 2004-06-02
DE69632625T2 (de) 2005-06-09
US6335181B1 (en) 2002-01-01
JP2008212160A (ja) 2008-09-18
JP2007044045A (ja) 2007-02-22
JP4276670B2 (ja) 2009-06-10
NZ301290A (en) 1998-12-23
US20040142453A1 (en) 2004-07-22
EP0807178A1 (fr) 1997-11-19
ES2217303T3 (es) 2004-11-01
CA2210928A1 (fr) 1996-08-08

Similar Documents

Publication Publication Date Title
NZ301290A (en) Mycobacterial proteins, micro-organisms producing same and vaccines thereof
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
DE69232782D1 (de) Zielgerichtetes Einbringen eines Virus-Vektors in Säugetierzellen.
DE69632827D1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
NO941381D0 (no) Colostrumfraksjon, fremgangsmåte for fremstilling og anvendelse av denne som et cellekulturmediumsupplement
PT698216E (pt) Metodos de tipificacao do virus da hepatite c e reagentes para utilizar nestes
DE69505804D1 (de) Afamin: ein menschliches serum albumin ähnliches protein
WO1995029236A3 (en) Lymphocyte activation antigens and antibodies thereto
DK0626452T3 (da) Vaccine mod infektion af Streptococcus suis
CY1108288T1 (el) Αντισωματα για το αντιγονο κυτταρων langerhans θηλαστικων και χρησεις τους
ATE350055T1 (de) Hämophilus influenzae adhärenz und penatrationsproteine
FR2677365B1 (fr) Proteines de mycobacterium et applications.
ATE221663T1 (de) Prionbindende proteine und deren verwendungen
FI930178A7 (fi) Määritys, menetelmä ja tuote perustuen n K+ kanava ilmenemiseen
DE69130845D1 (de) HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung
KR910005885A (ko) 단백질 c의 활성화방법
DE69434087D1 (de) ENTEROTOXINE VON SHIGELLA FLEXNERI 2a
WO1992011367A3 (en) Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
DE59000772D1 (de) Seitenstaendige carbazolyl-gruppen enthaltende methacrylat-(co)polymerisate und elektrophotographische aufzeichnungselemente, enthaltend dieselben.
ATE320266T1 (de) Induktion von antigen-spezifischen t-zellen durch interferon
EP1849800A3 (en) Moraxella catarrhalis proteins
EP0653752A3 (en) Dual voltage servo system and method.